GlaxoSmithKline’s £170 million Bioscience Campus will act as a leading centre in innovation in biotechnology and drug development. The project is to be funded by the Government, the Technology Strategy Board and EEDA, the Wellcome Trust and GSK.
Due to open in 2011, the science park will house 25 companies and is set to create 1,500 new jobs within the scientific industry. These staff will play an integral role in reaffirming the UK as a global hub of the life sciences industry. The 1500 staff will have access to GSK’s specialist skills, management and expertise in the area of drug discovery. This is welcome news for the scientific job market as there is strong potential for the site to grow fivefold within a decade. Speaking of the new Bioscience Campus, Business Secretary, Lord Mandelson stated, ‘The Stevenage Campus represents a huge investment in the future of Britain’s bioscience industry and is a strong new platform for the work of our Office for Life Sciences. It will leverage our existing strengths as a world leader in the sector, helping it to grow and reinforcing our international competitiveness. And ultimately it will help us build towards a stronger UK economy coming out of the global downturn.’